Abca1m4620Dajl/Abca1+
involves: C3H/HeSnJ * C57BL/6J * SWR
|
decreased circulating cholesterol level |
J:149088
|
decreased circulating HDL cholesterol level |
J:149088
|
Abca1m4620Dajl/Abca1m4620Dajl
involves: C3H/HeSnJ * C57BL/6J * SWR
|
decreased circulating cholesterol level |
J:149088
|
decreased circulating HDL cholesterol level |
J:149088
|
increased circulating triglyceride level |
J:149088
|
Abca1mpc227H/Abca1mpc227H
involves: BALB/c * C3H/HeH * C57BL/6J
|
decreased circulating cholesterol level |
J:234901
|
Abca1tm1.1Jp/Abca1tm1.1Jp
involves: 129S6/SvEvTac * C57BL/6
|
abnormal circulating phospholipid level |
J:98093
|
decreased circulating cholesterol level |
J:98093
|
decreased circulating HDL cholesterol level |
J:98093
|
Abca1tm1b(EUCOMM)Hmgu/Abca1+
C57BL/6N-Abca1tm1b(EUCOMM)Hmgu/Bay
|
abnormal retina morphology |
J:211773
|
unresponsive to tactile stimuli |
J:211773
|
Abca1tm1b(EUCOMM)Hmgu/Abca1tm1b(EUCOMM)Hmgu
C57BL/6N-Abca1tm1b(EUCOMM)Hmgu/Bay
|
abnormal embryo size |
J:211773
|
preweaning lethality, complete penetrance |
J:211773
|
unresponsive to tactile stimuli |
J:211773
|
Abca1tm1Blt/Abca1tm1Blt
C57BL/6-Abca1tm1Blt
|
abnormal platelet physiology |
J:95088
|
Abca1tm1Jdm/Abca1+
DBA/1LacJ-Abca1tm1Jdm
|
abnormal circulating phospholipid level |
J:61679
|
abnormal lipid homeostasis |
J:61679
|
abnormal lung morphology |
J:61679
|
decreased circulating cholesterol level |
J:61679
|
decreased circulating HDL cholesterol level |
J:61679
|
decreased circulating LDL cholesterol level |
J:61679
|
Abca1tm1Jdm/Abca1tm1Jdm
DBA/1-Abca1tm1Jdm/J
|
increased cholesterol efflux |
J:130777
|
Abca1tm1Jdm/Abca1tm1Jdm
DBA/1LacJ-Abca1tm1Jdm
|
abnormal circulating phospholipid level |
J:61679
|
abnormal fat-soluble vitamin level |
J:60210
|
abnormal lipid homeostasis |
J:61679
|
abnormal lung morphology |
J:61679
|
abnormal placenta development |
J:63265
|
abnormal pulmonary alveolus morphology |
J:61679
|
decreased body weight |
J:60210
|
decreased circulating cholesterol level |
J:60210,
J:61679
|
decreased circulating HDL cholesterol level |
J:60210,
J:61679
|
decreased circulating LDL cholesterol level |
J:61679
|
enlarged adrenal glands |
J:60210
|
enlarged spleen |
J:60210
|
female infertility |
J:63265
|
hemorrhage |
J:63265
|
impaired macrophage phagocytosis |
J:63265
|
increased intestinal cholesterol absorption |
J:61679
|
perinatal lethality, incomplete penetrance |
J:61679
|
postnatal lethality, incomplete penetrance |
J:63265
|
thrombocytopenia |
J:60210
|
Abca1tm1Jdm/Abca1tm1Jdm
involves: C57BL/6 * DBA/1LacJ
|
abnormal thymus morphology |
J:132254
|
decreased circulating cholesterol level |
J:132254
|
decreased circulating HDL cholesterol level |
J:132254
|
normal
homeostasis/metabolism phenotype |
J:132254
|
impaired macrophage phagocytosis |
J:132254
|
perinatal lethality, incomplete penetrance |
J:132254
|
Abca1tm1Jdm/Abca1tm1Jdm
involves: DBA/1LacJ
|
abnormal cholesterol homeostasis |
J:89906
|
abnormal Leydig cell morphology |
J:89906
|
abnormal seminiferous tubule epithelium morphology |
J:89906
|
abnormal seminiferous tubule morphology |
J:89906
|
abnormal Sertoli cell morphology |
J:89906
|
abnormal testosterone level |
J:89906
|
decreased cholesterol efflux |
J:89906
|
decreased circulating HDL cholesterol level |
J:89906
|
decreased circulating phytosterol level |
J:87209
|
oligozoospermia |
J:89906
|
reduced male fertility |
J:89906
|
seminiferous tubule degeneration |
J:89906
|
Abca1tm1Jp/Abca1+ Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
involves: 129S6/SvEvTac * B6.Cg-Tg(Alb-cre)21Mgn/J
|
abnormal cholesterol homeostasis |
J:98093
|
abnormal circulating phospholipid level |
J:98093
|
decreased circulating cholesterol level |
J:98093
|
decreased circulating HDL cholesterol level |
J:98093
|
Abca1tm1Jp/Abca1+ Tg(Vil1-cre)997Gum/0
involves: 129S6/SvEvTac * C57BL/6 * SJL
|
decreased circulating cholesterol level |
J:107802
|
decreased circulating HDL cholesterol level |
J:107802
|
Abca1tm1Jp/Abca1tm1Jp Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
involves: 129S6/SvEvTac * B6.Cg-Tg(Alb-cre)21Mgn/J
|
abnormal cholesterol homeostasis |
J:98093
|
abnormal circulating phospholipid level |
J:98093
|
decreased circulating cholesterol level |
J:98093
|
decreased circulating HDL cholesterol level |
J:98093
|
decreased circulating LDL cholesterol level |
J:98093
|
increased circulating triglyceride level |
J:98093
|
Abca1tm1Jp/Abca1tm1Jp Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
involves: 129S6/SvEvTac * C57BL/6 * DBA
|
decreased circulating HDL cholesterol level |
J:107802
|
Abca1tm1Jp/Abca1tm1Jp Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ Tg(Vil1-cre)997Gum/0
involves: 129S6/SvEvTac * C57BL/6 * DBA * SJL
|
decreased circulating HDL cholesterol level |
J:107802
|
Abca1tm1Jp/Abca1tm1Jp Tg(Vil1-cre)997Gum/0
involves: 129S6/SvEvTac * C57BL/6 * SJL
|
abnormal enterocyte physiology |
J:107802
|
decreased cholesterol efflux |
J:107802
|
decreased circulating cholesterol level |
J:107802
|
decreased circulating HDL cholesterol level |
J:107802
|
decreased circulating LDL cholesterol level |
J:107802
|
Abca1tm1Wpfl/Abca1+
involves: 129P2/OlaHsd * C57BL/6J
|
abnormal placenta labyrinth morphology |
J:64390
|
cardiomyopathy |
J:64390
|
decreased circulating cholesterol level |
J:64390
|
decreased circulating HDL cholesterol level |
J:64390
|
heart left ventricle hypertrophy |
J:64390
|
heart right ventricle hypertrophy |
J:64390
|
lung hemorrhage |
J:64390
|
reduced female fertility |
J:64390
|
respiratory distress |
J:64390
|
Abca1tm1Wpfl/Abca1tm1Wpfl
involves: 129 * C57BL/6
|
abnormal Sertoli cell morphology |
J:101966
|
Abca1tm1Wpfl/Abca1tm1Wpfl
involves: 129P2/OlaHsd * C57BL/6J
|
abnormal adrenal gland morphology |
J:64390
|
abnormal kidney cortex morphology |
J:64390
|
abnormal ovary morphology |
J:64390
|
abnormal placenta labyrinth morphology |
J:64390
|
abnormal Sertoli cell morphology |
J:64390
|
abnormal thymus morphology |
J:64390
|
abnormal uterus morphology |
J:64390
|
cardiomyopathy |
J:64390
|
decreased body size |
J:64390
|
decreased circulating cholesterol level |
J:64390,
J:68431
|
decreased circulating estradiol level |
J:64390
|
decreased circulating HDL cholesterol level |
J:64390,
J:68431
|
decreased circulating progesterone level |
J:64390
|
decreased intestinal cholesterol absorption |
J:68431
|
embryonic growth arrest |
J:64390
|
embryonic growth retardation |
J:64390
|
glomerulonephritis |
J:64390
|
glomerulosclerosis |
J:64390
|
heart left ventricle hypertrophy |
J:64390
|
heart right ventricle hypertrophy |
J:64390
|
lethality throughout fetal growth and development, incomplete penetrance |
J:64390
|
lung hemorrhage |
J:64390
|
macrovesicular hepatic steatosis |
J:64390
|
placenta hemorrhage |
J:64390
|
postnatal lethality, incomplete penetrance |
J:64390
|
reduced female fertility |
J:64390
|
renal glomerular immunoglobulin deposits |
J:64390
|
respiratory distress |
J:64390
|
uterus inflammation |
J:64390
|